Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Barry D. Quart files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sanj K. Patel - $39.43M of KNSA open-market activity in the last 12 months
- John F. Paolini - $8.00M of KNSA open-market activity in the last 12 months
- Eben Tessari - $7.24M of KNSA open-market activity in the last 12 months
- Mark Ragosa - $3.78M of KNSA open-market activity in the last 12 months
- Michael R. Megna - $2.66M of KNSA open-market activity in the last 12 months
- Ross Moat - $319K of KNSA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Barry D. Quart?
Barry D. Quart is a corporate insider, tracked as Director of Kiniksa Pharmaceuticals International, plc (KNSA). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Barry D. Quart submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Barry D. Quart been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($1.85M) across all tracked filings.
Where can I see all of Barry D. Quart's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Barry D. Quart and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
